375 related articles for article (PubMed ID: 32127941)
1. A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer.
Li X; Zhang Q; Zhao L; Jiang L; Qi A; Wei Q; Song X; Wang L; Zhang L; Zhao Y; Lv X; Wei M; Zhao L
J Cancer; 2020; 11(8):2139-2149. PubMed ID: 32127941
[No Abstract] [Full Text] [Related]
2. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas.
Wang X; Zhang W; Guo Y; Zhang Y; Bai X; Xie Y
World J Surg Oncol; 2023 Feb; 21(1):61. PubMed ID: 36823639
[TBL] [Abstract][Full Text] [Related]
3. Esophageal cancer lymph node metastasis-associated gene signature optimizes overall survival prediction of esophageal cancer.
Cai W; Li Y; Huang B; Hu C
J Cell Biochem; 2019 Jan; 120(1):592-600. PubMed ID: 30242875
[TBL] [Abstract][Full Text] [Related]
4. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
5. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
Yang G; Zhang Y; Yang J
Front Oncol; 2019; 9():1207. PubMed ID: 31799184
[TBL] [Abstract][Full Text] [Related]
6. A Robust 6-lncRNA Prognostic Signature for Predicting the Prognosis of Patients With Colorectal Cancer Metastasis.
Li S; Chen S; Wang B; Zhang L; Su Y; Zhang X
Front Med (Lausanne); 2020; 7():56. PubMed ID: 32211413
[No Abstract] [Full Text] [Related]
7. Establishment of a 7-microRNA prognostic signature and identification of hub target genes in colorectal carcinoma.
Jiang S; Xie X; Jiang H
Transl Cancer Res; 2022 Feb; 11(2):367-381. PubMed ID: 35281422
[TBL] [Abstract][Full Text] [Related]
8. Construction and Validation of a Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer.
Li S; Zhao Z; Yang H; Wang D; Sun W; Li S; Zhang Z; Fu W
Cancer Control; 2021; 28():10732748211027160. PubMed ID: 34155937
[TBL] [Abstract][Full Text] [Related]
9. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
10. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
12. TYMS serves as a prognostic indicator to predict the lymph node metastasis in Chinese patients with colorectal cancer.
Lu Y; Zhuo C; Cui B; Liu Z; Zhou P; Lu Y; Wang B
Clin Biochem; 2013 Oct; 46(15):1478-83. PubMed ID: 23810585
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer.
Yuanming L; Lineng Z; Baorong S; Junjie P; Sanjun C
BMC Cancer; 2013 Mar; 13():103. PubMed ID: 23496813
[TBL] [Abstract][Full Text] [Related]
14. Identification of a 6-gene signature predicting prognosis for colorectal cancer.
Zuo S; Dai G; Ren X
Cancer Cell Int; 2019; 19():6. PubMed ID: 30627052
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
Xia R; Tang H; Shen J; Xu S; Liang Y; Zhang Y; Gong X; Min Y; Zhang D; Tao C; Wang S; Zhang Y; Yang J; Wang C
Cancer Cell Int; 2021 Mar; 21(1):154. PubMed ID: 33663535
[TBL] [Abstract][Full Text] [Related]
16. Construction and Validation of a Novel Ferroptosis-Related lncRNA Signature to Predict Prognosis in Colorectal Cancer Patients.
Zhang W; Fang D; Li S; Bao X; Jiang L; Sun X
Front Genet; 2021; 12():709329. PubMed ID: 34777458
[No Abstract] [Full Text] [Related]
17. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
[TBL] [Abstract][Full Text] [Related]
18. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Value Investigation and Bioinformatics Analysis of miR-31 in Patients with Lymph Node Metastasis of Colorectal Cancer.
Zhang WW; Ming XL; Rong Y; Huang CQ; Weng H; Chen H; Bian JM; Wang FB
Anal Cell Pathol (Amst); 2019; 2019():9740475. PubMed ID: 31934534
[TBL] [Abstract][Full Text] [Related]
20. Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer.
Wang TB; Chen ZG; Wei XQ; Wei B; Dong WG
ANZ J Surg; 2011 Oct; 81(10):694-9. PubMed ID: 22295309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]